Cite
Mutations in TERT, the Gene Encoding Telomerase Reverse Transcriptase, in “Acquired” Aplastic Anemia Inhibit Enzymatic Function by a Dominant Negative Mechanism of Action.
MLA
Calado, Rodrigo T., et al. “Mutations in TERT, the Gene Encoding Telomerase Reverse Transcriptase, in ‘Acquired’ Aplastic Anemia Inhibit Enzymatic Function by a Dominant Negative Mechanism of Action.” Blood, vol. 104, no. 11, Nov. 2004, p. 3. EBSCOhost, https://doi.org/10.1182/blood.V104.11.3.3.
APA
Calado, R. T., Ly, H., Yamaguchi, H., Baerlocher, G. M., Kajigaya, S., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2004). Mutations in TERT, the Gene Encoding Telomerase Reverse Transcriptase, in “Acquired” Aplastic Anemia Inhibit Enzymatic Function by a Dominant Negative Mechanism of Action. Blood, 104(11), 3. https://doi.org/10.1182/blood.V104.11.3.3
Chicago
Calado, Rodrigo T., Hinh Ly, Hiroki Yamaguchi, Gabriela M. Baerlocher, Sachiko Kajigaya, Stephen J. Chanock, Peter M. Lansdorp, and Neal S. Young. 2004. “Mutations in TERT, the Gene Encoding Telomerase Reverse Transcriptase, in ‘Acquired’ Aplastic Anemia Inhibit Enzymatic Function by a Dominant Negative Mechanism of Action.” Blood 104 (11): 3. doi:10.1182/blood.V104.11.3.3.